These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 30351956)
1. Effect of Surfactant-Bile Interactions on the Solubility of Hydrophobic Drugs in Biorelevant Dissolution Media. Vinarov Z; Katev V; Burdzhiev N; Tcholakova S; Denkov N Mol Pharm; 2018 Dec; 15(12):5741-5753. PubMed ID: 30351956 [TBL] [Abstract][Full Text] [Related]
2. Micellar solubilization of poorly water-soluble drugs: effect of surfactant and solubilizate molecular structure. Vinarov Z; Katev V; Radeva D; Tcholakova S; Denkov ND Drug Dev Ind Pharm; 2018 Apr; 44(4):677-686. PubMed ID: 29164955 [TBL] [Abstract][Full Text] [Related]
3. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility. Enright EF; Joyce SA; Gahan CG; Griffin BT Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768 [TBL] [Abstract][Full Text] [Related]
4. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs. Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297 [TBL] [Abstract][Full Text] [Related]
5. Synergistic and antagonistic effects of non-ionic surfactants with bile salt + phospholipid mixed micelles on the solubility of poorly water-soluble drugs. Clulow AJ; Barber B; Salim M; Ryan T; Boyd BJ Int J Pharm; 2020 Oct; 588():119762. PubMed ID: 32814153 [TBL] [Abstract][Full Text] [Related]
6. Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs. Lehto P; Kortejärvi H; Liimatainen A; Ojala K; Kangas H; Hirvonen J; Tanninen VP; Peltonen L Eur J Pharm Biopharm; 2011 Aug; 78(3):531-8. PubMed ID: 21329757 [TBL] [Abstract][Full Text] [Related]
7. Probing the molecular interactions between pharmaceutical polymeric carriers and bile salts in simulated gastrointestinal fluids using NMR spectroscopy. Pigliacelli C; Belton P; Wilde P; Qi S J Colloid Interface Sci; 2019 Sep; 551():147-154. PubMed ID: 31075629 [TBL] [Abstract][Full Text] [Related]
8. Influence of Hydrophobic and Hydrophilic Chain Length of C Kroll P; Exner L; Brandenbusch C; Sadowski G Mol Pharm; 2023 Feb; 20(2):1296-1306. PubMed ID: 36565283 [TBL] [Abstract][Full Text] [Related]
9. Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design. Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW Mol Pharm; 2017 Dec; 14(12):4132-4144. PubMed ID: 28749696 [TBL] [Abstract][Full Text] [Related]
10. Physicochemical Properties of Solid Phospholipid Particles as a Drug Delivery Platform for Improving Oral Absorption of Poorly Soluble Drugs. Kawakami K; Miyazaki A; Fukushima M; Sato K; Yamamura Y; Mohri K; Sakuma S Pharm Res; 2017 Jan; 34(1):208-216. PubMed ID: 27822849 [TBL] [Abstract][Full Text] [Related]
11. Albendazole solution formulation via vesicle-to-micelle transition of phospholipid-surfactant aggregates. Vinarov Z; Gancheva G; Katev V; Tcholakova SS Drug Dev Ind Pharm; 2018 Jul; 44(7):1130-1138. PubMed ID: 29412014 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach. Fei Y; Kostewicz ES; Sheu MT; Dressman JB Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116 [TBL] [Abstract][Full Text] [Related]
13. Topography of Simulated Intestinal Equilibrium Solubility. Dunn C; Perrier J; Khadra I; Wilson CG; Halbert GW Mol Pharm; 2019 May; 16(5):1890-1905. PubMed ID: 30848917 [TBL] [Abstract][Full Text] [Related]
14. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media. Ottaviani G; Wendelspiess S; Alvarez-Sánchez R Mol Pharm; 2015 Apr; 12(4):1171-9. PubMed ID: 25665011 [TBL] [Abstract][Full Text] [Related]
15. Combining in vitro and in silico methods for better prediction of surfactant effects on the absorption of poorly water soluble drugs-a fenofibrate case example. Berthelsen R; Sjögren E; Jacobsen J; Kristensen J; Holm R; Abrahamsson B; Müllertz A Int J Pharm; 2014 Oct; 473(1-2):356-65. PubMed ID: 24997410 [TBL] [Abstract][Full Text] [Related]
16. Kolliphor surfactants affect solubilization and bioavailability of fenofibrate. Studies of in vitro digestion and absorption in rats. Berthelsen R; Holm R; Jacobsen J; Kristensen J; Abrahamsson B; Müllertz A Mol Pharm; 2015 Apr; 12(4):1062-71. PubMed ID: 25679417 [TBL] [Abstract][Full Text] [Related]
17. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion. Mohsin K AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370 [TBL] [Abstract][Full Text] [Related]
18. Prediction of In Vitro Drug Dissolution into Fed-state Biorelevant Media: Contributions of Solubility Enhancement and Relatively Low Colloid Diffusivity. Jamil R; Polli JE Eur J Pharm Sci; 2022 Jun; 173():106179. PubMed ID: 35367356 [TBL] [Abstract][Full Text] [Related]
19. A mechanistic study of danazol dissolution in ionic surfactant solutions. Sun W; Larive CK; Southard MZ J Pharm Sci; 2003 Feb; 92(2):424-35. PubMed ID: 12532392 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of drug solubilization by polar lipids in biorelevant media. Katev V; Vinarov Z; Tcholakova S Eur J Pharm Sci; 2021 Apr; 159():105733. PubMed ID: 33497822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]